Trinity Capital Declares Monthly Cash Distribution of $0.17 per Share for the Second Quarter of 2026
Rhea-AI Summary
Trinity Capital (Nasdaq: TRIN) declared a monthly regular dividend of $0.17 per share for April, May and June 2026.
Declaration date for all three payments was March 18, 2026; record dates are April 15, May 15 and June 11, 2026, with payment dates April 30, May 29 and June 30, 2026. The company said it targets distributing roughly 90%–100% of taxable quarterly income to maintain RIC tax treatment.
Positive
- Monthly dividend of $0.17 per share for Q2 2026
- All three dividends declared on March 18, 2026
- Dividend consistency maintained for >6 years
- RIC distribution policy aims for 90%–100% of taxable income
Negative
- Dividends may include return of capital, affecting tax basis
- Company may spill excess taxable income into future years, creating payout variability
News Market Reaction – TRIN
In the Mar 19 session, TRIN gained 0.55%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 16 | Joint venture formed | Positive | -1.2% | Announced 50/50 JV with CSWC with initial equity commitments of $100 million. |
| Mar 12 | Growth capital deal | Positive | -0.7% | Committed $35 million in growth capital to Monteris Medical for NeuroBlate expansion. |
| Mar 11 | Growth capital deal | Positive | -0.6% | Provided $20 million to Emboline to support Emboliner commercialization preparations. |
| Mar 11 | Portfolio company funding | Positive | -0.6% | Emboline highlighted $20 million growth capital from TRIN for Emboliner platform. |
| Mar 10 | Growth capital deal | Positive | +0.2% | Committed $35 million to Neuros Medical to scale FDA-approved Altius therapy adoption. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent ostensibly positive portfolio and partnership announcements have often coincided with flat to negative next-day price moves, suggesting a tendency for the stock to underreact or fade after good news.
Over the last several days, Trinity Capital has reported multiple growth-capital commitments and a new joint venture. On March 10, 2026, it provided $35 million to Neuros Medical, followed by separate $20 million and $35 million financings to Emboline and Monteris Medical. On March 16, 2026, TRIN formed a $100 million 50/50 joint venture with Capital Southwest. Despite these seemingly growth-oriented updates, share reactions ranged from about -1.18% to modestly positive, so today’s steady, maintained dividend fits into a narrative of incremental rather than transformative catalysts.
Key Terms
regulated investment company regulatory
return of capital financial
capital gains financial
Internal Revenue Code of 1986 regulatory
Form 1099-DIV regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.
TRIN dividend has remained consistent for more than six years
This is an equivalent monthly distribution as the first three months of 2026. Trinity Capital shareholders have now received a consistent or increased dividend for more than six years straight.
Summary of the upcoming dividends for the Second Quarter 2026:
Period | April 2026 | May 2026 | June 2026 |
Declaration Date | March 18, 2026 | March 18, 2026 | March 18, 2026 |
Record Date | April 15, 2026 | May 15, 2026 | June 11, 2026 |
Payment Date | April 30, 2026 | May 29, 2026 | June 30, 2026 |
Amount per share |
The Company's objective is to distribute regular dividends in an amount that approximates
Dividends are paid from taxable earnings and may include a return of capital and/or capital gains. The specific tax characteristics of the dividends will be reported to stockholders on Form 1099-DIV after the end of the calendar year and in the Company's periodic reports filed with the Securities and Exchange Commission.
About Trinity Capital Inc.
Trinity Capital Inc. (Nasdaq: TRIN) is an international alternative asset manager that seeks to deliver consistent returns for investors through access to private credit markets. Trinity Capital sources and structures investments in well-capitalized growth-oriented companies across five distinct lending verticals: Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences. As a long-term, trusted partner for innovative companies seeking tailored debt solutions, Trinity Capital has deployed more than
Forward-Looking Statements
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements other than statements of historical facts included in this press release may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described from time to time in filings with the Securities and Exchange Commission ("SEC"). The Company undertakes no duty to update any forward-looking statement made herein, unless required by law. All forward-looking statements speak only as of the date of this press release. More information on risks and other potential factors that could affect the Company's financial results, including important factors that could cause actual results to differ materially from plans, estimates or expectations, is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed annual report on Form 10-K and subsequent SEC filings.
View original content to download multimedia:https://www.prnewswire.com/news-releases/trinity-capital-declares-monthly-cash-distribution-of-0-17-per-share-for-the-second-quarter-of-2026--302717727.html
SOURCE Trinity Capital Inc.